Ischaemiás prekondicionálás az agyban.

Translated title of the contribution: Ischemic preconditioning in the brain

Krisztina Nagy, F. Domoki, F. Bari

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Stroke-related death is the third most common cause of mortality in Hungary after cardiovascular diseases and cancer. In addition to the unfavourable mortality figures, the consequent development of neurological and psychiatric disorders in stroke patients imposes an enormous burden on the health care system and on the families. Numerous studies are being conducted world wide on the prevention of stroke and other cerebrovascular disorders like chronic hypoperfusion, as well as on acute stroke management and patient rehabilitation issues. As a result, our understanding of the mechanism of hypoxic brain damage steadily increased over the past years and decades which brought along promising achievements both in the field of stroke prevention and therapy. However, these broad-spectrum approaches also made clear that preventing neuronal death and thus reducing neurological damage are complex tasks that cannot be successfully resolved by targeting single mechanisms. Therefore, the development of alternative new drugs and clinically applicable complex neuroprotective strategies is warranted. One of the most promising approaches is to create ischemic tolerance in the brain by using pharmacological preconditioning paradigms. These drugs trigger similar events to those initiated by brief ischemic insults that later can make the cerebral tissue resistant to subsequent otherwise lethal stress (ischemic preconditioning).

Original languageHungarian
Pages (from-to)305-313
Number of pages9
JournalIdeggyógyászati szemle
Volume58
Issue number9-10
Publication statusPublished - Sep 20 2005

Fingerprint

Ischemic Preconditioning
Stroke
Brain
Cerebrovascular Disorders
Brain Hypoxia
Mortality
Hungary
Nervous System Diseases
Pharmaceutical Preparations
Psychiatry
Cardiovascular Diseases
Rehabilitation
Pharmacology
Delivery of Health Care
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ischaemiás prekondicionálás az agyban. / Nagy, Krisztina; Domoki, F.; Bari, F.

In: Ideggyógyászati szemle, Vol. 58, No. 9-10, 20.09.2005, p. 305-313.

Research output: Contribution to journalArticle

Nagy, Krisztina ; Domoki, F. ; Bari, F. / Ischaemiás prekondicionálás az agyban. In: Ideggyógyászati szemle. 2005 ; Vol. 58, No. 9-10. pp. 305-313.
@article{6c477b55c6f1449096a6427fea1fd120,
title = "Ischaemi{\'a}s prekondicion{\'a}l{\'a}s az agyban.",
abstract = "Stroke-related death is the third most common cause of mortality in Hungary after cardiovascular diseases and cancer. In addition to the unfavourable mortality figures, the consequent development of neurological and psychiatric disorders in stroke patients imposes an enormous burden on the health care system and on the families. Numerous studies are being conducted world wide on the prevention of stroke and other cerebrovascular disorders like chronic hypoperfusion, as well as on acute stroke management and patient rehabilitation issues. As a result, our understanding of the mechanism of hypoxic brain damage steadily increased over the past years and decades which brought along promising achievements both in the field of stroke prevention and therapy. However, these broad-spectrum approaches also made clear that preventing neuronal death and thus reducing neurological damage are complex tasks that cannot be successfully resolved by targeting single mechanisms. Therefore, the development of alternative new drugs and clinically applicable complex neuroprotective strategies is warranted. One of the most promising approaches is to create ischemic tolerance in the brain by using pharmacological preconditioning paradigms. These drugs trigger similar events to those initiated by brief ischemic insults that later can make the cerebral tissue resistant to subsequent otherwise lethal stress (ischemic preconditioning).",
author = "Krisztina Nagy and F. Domoki and F. Bari",
year = "2005",
month = "9",
day = "20",
language = "Hungarian",
volume = "58",
pages = "305--313",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "9-10",

}

TY - JOUR

T1 - Ischaemiás prekondicionálás az agyban.

AU - Nagy, Krisztina

AU - Domoki, F.

AU - Bari, F.

PY - 2005/9/20

Y1 - 2005/9/20

N2 - Stroke-related death is the third most common cause of mortality in Hungary after cardiovascular diseases and cancer. In addition to the unfavourable mortality figures, the consequent development of neurological and psychiatric disorders in stroke patients imposes an enormous burden on the health care system and on the families. Numerous studies are being conducted world wide on the prevention of stroke and other cerebrovascular disorders like chronic hypoperfusion, as well as on acute stroke management and patient rehabilitation issues. As a result, our understanding of the mechanism of hypoxic brain damage steadily increased over the past years and decades which brought along promising achievements both in the field of stroke prevention and therapy. However, these broad-spectrum approaches also made clear that preventing neuronal death and thus reducing neurological damage are complex tasks that cannot be successfully resolved by targeting single mechanisms. Therefore, the development of alternative new drugs and clinically applicable complex neuroprotective strategies is warranted. One of the most promising approaches is to create ischemic tolerance in the brain by using pharmacological preconditioning paradigms. These drugs trigger similar events to those initiated by brief ischemic insults that later can make the cerebral tissue resistant to subsequent otherwise lethal stress (ischemic preconditioning).

AB - Stroke-related death is the third most common cause of mortality in Hungary after cardiovascular diseases and cancer. In addition to the unfavourable mortality figures, the consequent development of neurological and psychiatric disorders in stroke patients imposes an enormous burden on the health care system and on the families. Numerous studies are being conducted world wide on the prevention of stroke and other cerebrovascular disorders like chronic hypoperfusion, as well as on acute stroke management and patient rehabilitation issues. As a result, our understanding of the mechanism of hypoxic brain damage steadily increased over the past years and decades which brought along promising achievements both in the field of stroke prevention and therapy. However, these broad-spectrum approaches also made clear that preventing neuronal death and thus reducing neurological damage are complex tasks that cannot be successfully resolved by targeting single mechanisms. Therefore, the development of alternative new drugs and clinically applicable complex neuroprotective strategies is warranted. One of the most promising approaches is to create ischemic tolerance in the brain by using pharmacological preconditioning paradigms. These drugs trigger similar events to those initiated by brief ischemic insults that later can make the cerebral tissue resistant to subsequent otherwise lethal stress (ischemic preconditioning).

UR - http://www.scopus.com/inward/record.url?scp=33644654686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644654686&partnerID=8YFLogxK

M3 - Article

C2 - 16252891

AN - SCOPUS:33644654686

VL - 58

SP - 305

EP - 313

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 9-10

ER -